Clinical Trial Update: The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain [Phase 2]

View source ↗

Summary

Phase 2 trial investigating selective oxytocin receptor inhibitors for endometriosis-related pain. Status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endometriosis | Phase 2 | Status: UNKNOWN